MAWI team is a band of engineers and tech entrepreneurs who are specialized in AI-powered consumer-oriented medical devices.
We are the Mawi band! Our team of talented engineers has a great passion for Data Science, Artificial intelligence, and Machine learning. For years we have been working on the research that eventually established the company’s mission – to make the heart data accessible to each person and to prevent the heart’s “silent killers”.
Keeping this in mind, we have transformed our science into a number of unique products that are able to detect heart diseases in the early stages.
Their main goal is to change the Remote Patient Monitoring paradigm, providing Healthcare professionals the ability to track their patients continuously. By collecting all the main vital signs, we help physicians receive a full picture of patients’ health instead of snapshots from a visit to visit.
About Failsafe Air Safety Systems (FASS)
Over 17 years of Experience at Your Service. Get clean, contaminant-free air.
FailSafe Air Safety Systems make a series of air purification and decontamination machines that can reduce the spread of airborne pathogens. FASS devices capture, contain, and neutralize airborne contaminants and prevent contamination of filters from pathogen growth.
Each machine uses an array of proven technologies in a patented process that trap pathogens as small as viruses, and bacteria as large as fungi.
Protect against surface contamination
FailSafe Air Safety Systems’ machines allow the user to decontaminate the environment, from airborne and surface resident particles.
A user-activated, high level ozone bath is produced, purifying the air and decontaminating surfaces.
While bleach or other traditional decontamination methods are effective, they can cause damage and often cannot access all surfaces—such as ceiling tiles and window joints.
The use of ozone minimizes damage to surfaces without compromising performance.
About Chlorem (Remchol)
Cholrem inc. is a specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs.
More and more companies are beginning to research end products for cyclodextrin but are years away from having approved products ready for market. Some of these companies are solely dedicated to cyclodextrin research and are valued in excess of $100 million without a single commercial product.
While these companies struggle to develop a product for a dedicated treatment, Cholrem has developed its own cyclodextrin (CAVADEX®) and has moved forward and made CAVADEX® available for general use. Much like a vitamin, Cholrem inc. products provide immediate access to CAVADEX® by the consumer and as the science shows, CAVADEX® can’t harm you but instead every dose you take is doing some good for your overall health.
Cholrem inc. is the only company with a commercially available cyclodextren treatment. Our first product, the RemChol enema, is now available giving consumers immediate access to this incredible compound. The Cholrem inc. products are designed to deliver up to 8 grams of CAVADEX® daily. This accumulates to over 2,400 grams per year, providing huge health benefits to the consumer.
As the science continues to show the benefits of cyclodextrin, Cholrem inc. is ready to satisfy the increasing demand for this new health improving treatment.
Research into cyclodextrin is quickly proving that cyclodextrin will emerge as a major therapeutically beneficial product for the 2020’s decade.
Scientific studies and research into cyclodextrin are showing that enhanced cholesterol transport within the body has major benefits in a huge range of health issues, including Atherosclerosis, Alzheimer disease, Kidney disease, Macular degeneration etc.
Tyto Care is transforming primary care by putting health in the hands of consumers. TytoCare seamlessly connect people to clinicians to provide the best home examination and diagnosis solutions.